<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Acknowledgements</title>
 <p>The authors would like to thank WEPON Pharmaceutical Group Co. Ltd. for access to their preliminary results on their clinical study project, entitled “Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined with Standard Treatment/ Standard Treatment in Patients with Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)”, officially released on Clinical Trials, with a registration number NCT04273763.</p>
</ack>
